Appendix

Central and Site Responsibilities (Exceptions Table)

Edition
Network Edition 2.0
Approx. pages
6

[YELLOW] the site fills in. [DEFAULT: green] a value the site may keep or change.

On this page

1. How to use this appendix

This appendix applies only in Model N. It does two things. Part 1 lists, once, the duties that always stay at the member site. Part 2 lists the activities a network may centralize, with a default for each. Any activity not listed in Part 2 is done by the member site as its Lean Edition SOP says.

Steps:

  • The Hybrid Rule (SOP-N1 5.2.2) applies to every row. The N-Integrated column applies only to a member site that is the network entity (type a). For every other member site, including a commonly owned subsidiary or a professional corporation under a management services arrangement (type b) and an independent entity (type c), the N-Affiliated column applies to every row.
  • A separate entity uses a different cell only under a row-specific exception that counsel confirms in writing for that site and row, recorded on F-900-02 Part 4 with the counsel reference and, where work or PHI crosses a legal-entity line, the staffing agreement and F-905-01 flow that cover it (SOP-N1 5.2.4). A general grant of authority in the network agreement is not an exception. Approval follows SOP-N1 5.2.5.
  • An affiliated covered entity (ACE) never makes a Network Office activity a use unless the network entity is itself a covered entity and an ACE member. Otherwise the Network Office acts for the ACE members as a business associate under a BAA (SOP-N6 5.3.3).
  • Never use a row to move a Part 1 duty away from the site. The Network Office may support a Part 1 duty (for example by preparing a form for the PI to sign), but the site person named in the Lean SOP still performs and signs it.
  • Where a separate entity's network agreement is silent on a row, the site performs the activity (S) until the agreement is amended.

Codes: C means the Network Office performs the activity and keeps the record; S means the member site does; C/S means shared, with the split stated in the cell. The procedure for each row is in the Network SOP or Supplement section cited; this table says only who.

Part 1. Duties that always stay at the site

Investigator duties. The PI and the investigators listed for the study at the site keep the duties in 21 CFR 312.60 to 312.69, 21 CFR 812.100 to 812.150 and ICH E6(R3) Annex 1, section 2. In particular:

  • signing the Form FDA 1572 or investigator agreement, submissions to the IRB, the eCRF and reports
  • delegating tasks and signing the site's delegation log (F-302-01), and supervising everyone who does delegated work, whoever employs them
  • informed consent, done by staff on the site's delegation log with the site's IRB-approved form
  • eligibility decisions and sign-off on F-303-02
  • medical care, AE assessment (seriousness, severity, causality, expectedness) and SAE reports sent by the site directly to the sponsor
  • classifying protocol deviations and deciding what is reported to the IRB
  • emergency unblinding decisions
  • control of and accountability for IP received for the site
  • accurate source and records, and control of the site's essential records for the full retention period
  • permitting monitoring, audit and inspection, receiving the Form FDA 482 and 483, and signing the response
  • deciding whether to take an allocated study, and any pause of enrollment

Legal-entity and location duties. These attach to the legal entity or the licensed location:

  • HIPAA covered entity duties of each covered entity, (45 CFR 164.530), including breach decisions (45 CFR 164.400 to 164.414); for separate entities, each entity's own Privacy Officer and Security Officer
  • CLIA certificate for each testing location (42 CFR 493.35(b), 493.55(b))
  • DEA registration for each registrant and location where controlled substances are stored or dispensed (21 CFR 1301.12), and state controlled-substance registration
  • state facility, pharmacy and other licenses for each location
  • employer duties, including DOT hazmat training records for its own employees (49 CFR 172.702(a)) and tax reporting as payer
  • submitting claims under the entity's own billing numbers and the overpayment duty
  • for a separate entity: signing its own contracts unless it has given written authority; deciding conflicts of interest and management plans for its own staff; custody of its own study records

Site-run activities. Conducting study visits and procedures; eliciting AEs; completing F-205-01 for each study, signed by the site PI and Site Director; keeping the site's business continuity plan (F-705-01) and first response to temperature alarms; hosting audits and inspections.

Part 2. Activities a network may centralize

Row IDActivityLean SOPN-Integrated defaultN-Affiliated defaultCondition
B-01Network SOP system: master index, editable master, publication, network minimumsSOP-01CCEach separate entity adopts on F-100-01 before a network SOP binds it (SOP-N1 5.5.4)
B-02Role curricula, network courses and central training recordsSOP-01C/S: C sets and delivers; S adds local and state items and confirms completionC/S: same where the agreement includes training; S keeps its own recordsRecords retrievable by the site for monitors and inspectors
B-03Qualification files, license verification, debarment and exclusion screeningSOP-01; SOP-M1CSCentral screen for a separate entity only if its agreement says so; the employer stays responsible (SOP-N5 5.3.2)
B-04Appendix A worksheet per stateSOP-01C/S: C prepares with counsel; S confirmsC/S: same; each entity confirms with its own counselIncludes corporate practice of medicine and state all-payer anti-kickback answers (SOP-N1 5.2.3; SOP-N3 5.7.3)
B-05Organization chart, role descriptions, onboarding and offboardingSOP-02CS: C handles only accounts in network systemsNetwork Office directs a separate entity's staff only as its agreement allows (SOP-N5 5.6.2)
B-06Conflict of interest collection and review, network and platform-wide interestsSOP-02CC/S: S decides for its own staff; C collects network interestsRecusal only for a site-specific interest (SOP-N3 5.4.4)
B-07Prepare 1572, investigator agreement, financial disclosure and regulatory packetSOP-02; SOP-03C/S: C prepares; PI checks and signsC/S: same where the agreement includes regulatory servicesNo use of a PI's credentials
B-08IRB of record, reliance agreements and IRB accountsSOP-03C: network entity signs onceC/S: C arranges; each engaged entity signsC signs for a separate entity only with written authority the IRB accepts
B-09IRB submissions: initial, amendments, continuing review, reportable eventsSOP-03; SOP-09C/S: C prepares and submits; PI approves contentC/S: samePI decides reportability
B-10Host ISFs in a central eISF or eRegulatory systemSOP-03CC/S: only where the agreement gives the site control, access and full exportFlow on F-905-01 (SOP-N6 5.7)
B-11Consent template and release of IRB-approved site versionsSOP-04C/S: C releases; S uses only its own version and withdraws superseded copiesC/S: sameA version approved for one site is never used at another
B-12Central or remote consent staffSOP-04C/S: delegated on the site log and trainedC/S: same plus staffing agreementIRB approval for remote consent
B-13Second-person consent QC and eligibility review; routine QC samplingSOP-04; SOP-05; SOP-14C/S: delegated central reviewer; network sampling scheme allowedS, or C/S under a staffing agreement and a PHI pathway on F-905-01Access to site records under SOP-N6. PI or Sub-I signs eligibility
B-14Central pre-screening or call centerSOP-05; SOP-M3C/S: delegated staff use the site script; F-300-01 shows receiving siteC/S: sameWaiver or authorization for record review (SOP-N6 5.5.2)
B-15Duplicate or concurrent enrollment check across sitesSOP-05C: use within the entity, match or no matchC: one-way hashed match, match or no match, under a BAA (also for ACE members unless the network entity is an ACE member)BAA expressly permitting it; consent and authorization or waiver covers it (SOP-N6 5.5.4)
B-16Shared unblinded pharmacist or IP ManagerSOP-05; SOP-06C/S: named unblinded on each site's F-302-01C/S: same under a staffing agreementNever a blinded role in the same study
B-17Central pharmacy or IP depotSOP-06CC under a services agreement, with a BAA where PHI is handledSponsor written approval; listed on each 1572; pharmacy law met; DEA registration for the location, and a Schedule I researcher registration for any Schedule I IP. Default is direct shipment; routine controlled-substance redistribution only after counsel confirms registration (SOP-N5 5.8.3)
B-18Central data entry and query resolutionSOP-07C/S: delegated, own EDC account, from site sourceS, or C/S under a staffing agreement and a BAA (F-905-01)Site PI or Sub-I signs the eCRF
B-19Network EHR or eSource systemSOP-07CS, or a network system under an agreementAgreement covers access, ownership and return; F-905-01
B-20Cross-site deviation and CAPA trending; network-wide CAPASOP-08CC/S: S takes part as the agreement requiresSite still classifies, reports and runs its own CAPA (SOP-N4 5.8.2)
B-21SAE reporting timeliness trackingSOP-09C: from datesC/S: days and protocol timeline onlyMore only under F-905-01. Never assesses seriousness or causality (SOP-N4 5.3.2)
B-22Receive and distribute sponsor safety reports; keep IRB policy summariesSOP-09C/S: C distributes; PI acknowledgesC/S: sameAcknowledgment filed in the site ISF
B-23Central participant payment programSOP-10C: network entity is payerC/S: payer named in the agreementC is payer for payments from its own account; F-905-01 (SOP-N3 5.7.7)
B-24Specimen processing hub or network laboratorySOP-11CC/S under a services agreement, with a BAA where PHI travels with specimensSponsor-approved routing; CLIA certificate for the location where results are used for care (SOP-N5 5.8.4)
B-25Equipment and calibration program and vendor contractsSOP-11C/S: C runs schedule; F-312-01 shows owning siteS, with network contracts offeredWritten agreement for equipment used across entities
B-26Privacy Officer and privacy programSOP-12C: one Privacy Officer for the network entityS: each covered entity's own Privacy Officer (an ACE may designate one for its members); C supports under a BAABreach decisions per covered entity (SOP-N6 5.8)
B-27Shared systems: inventory, fitness for purpose, access grants and reviewsSOP-12C/S: C grants after Site Director approvalC/S: samePathway on F-905-01; each entity's own Part 11 letter (SOP-N6 5.2)
B-28Central archive and retrievalSOP-12CC/S under a written custody agreementSite approves destruction
B-29Monitoring visit scheduling, follow-up tracking, audit and inspection liaison supportSOP-13C/S: C coordinates and supports; PI answers and signsS, with C support as the Site Director agreesSite tells the Network Office the same business day
B-30Central QA audits, including the annual internal auditSOP-14CC/S: only as the agreement allowsAuditor independent of the site (SOP-N4 5.5)
B-31Quarterly scorecard and network metricsSOP-14CC/S: S submits dataData cross only as listed on F-905-01 (SOP-N4 5.3)
B-32Financial closeout and reconciliationSOP-15CC/S: payee named in the CTA reconcilesNetwork Office fee only as set in the agreement (SOP-N3 5.7.4)
B-33Network continuity plan, coverage roster, backup storage at another siteSOP-16C/S: C keeps network plan and roster; S keeps F-705-01C/S: sameBackup storage needs sponsor approval; written agreement between entities
B-34Qualify vendors once for the network; record central services as providersSOP-M1CC/S: S may rely where the agreement allowsPI approves use for each study; business associate chain in place
B-35Central intake, CDAs, network feasibility response and allocationSOP-M2CCCDA permits disclosure or the entity signs a joinder; Network Office never raises a site estimate (SOP-N3 5.2, 5.3)
B-36Negotiate CTAs, master agreements and budget exhibitsSOP-M2CC/S: C negotiates; S approves its budget exhibitSite Director approves each site budget
B-37Sign CTAsSOP-M2CS, tri-party, or C signs as the entity's agent under written authority in the network agreementNetwork entity signs alone only where the agreement and sponsor accept it and counsel confirms (SOP-N3 5.5.2)
B-38Coverage analysis and research claim reviewSOP-M2C/S: C prepares; billing entity decides billing and localizesC/S: sameCentral claim review of a separate entity only under a BAA and F-905-01
B-39Invoicing, collection and payment of member entitiesSOP-M2CC/S: payee named in the CTA invoices; C pays share under the agreementCounsel review under SOP-N3 5.7.3
B-40Network advertising and volunteer databaseSOP-M3CC/S: entries only with agreement or authorization naming the networkEach material IRB-approved for every site it names (SOP-N6 5.5.3)
B-41Home health, telehealth service and licensure registerSOP-M4CC/S under a staffing or services agreement and a BAA (F-905-01)Staff delegated per site; licensed where the participant is
B-42Integrity reporting channel and investigationsSOP-M5CC/S: network channel added to the entity routeInvestigations of a separate entity only as the agreement allows
B-43IND or IDE holder and sponsor tasks for a multi-site sponsor-investigator studySOP-M6C/S: holder recorded before submissionC/S: sameNetwork Office never takes investigator duties at the PI's site

Independent Site SOP Library. Licensed CC BY-NC 4.0 by the American Institute for Medical Research (AIMR), with added permission for any site's internal use (license terms). Not legal advice: each adopting site confirms state law, IRB and sponsor requirements with its own counsel and owns every step it approves.